Pacemaker-related infection detected by 18F-fluorodeoxyglucose positron emission tomography–computed tomography  by de Lima Peixoto, Giselle et al.
International Journal of Infectious Diseases 19 (2014) 87–90Case Report
Pacemaker-related infection detected by 18F-ﬂuorodeoxyglucose
positron emission tomography–computed tomography
Giselle de Lima Peixoto *, Rinaldo Focaccia Siciliano, Raphael Abega˜o Camargo,
Fabiana Lucas Bueno, Jose´ Soares Ju´nior, Roberto Costa, Taˆnia Mara Vareja˜o Strabelli,
Martino Martinelli Filho
Heart Institute (InCor), Hospital das Clı´nicas da Faculdade de Medicina da Universidade de Sa˜o Paulo, Av. Ene´as de Caravalho Aguiar, 44, CEP 05403-000, Sa˜o
Paulo, SP, Brazil
A R T I C L E I N F O
Article history:
Received 5 July 2013
Received in revised form 28 September 2013
Accepted 2 October 2013







S U M M A R Y
Lead endocarditis (LE) is one of the most feared complications and remains a challenging diagnosis in
cardiology due to the possibility of an obscure clinical course and symptoms, leading to a delayed
diagnosis, or even no diagnosis. 18F-ﬂuorodeoxyglucose positron emission tomography–computed
tomography (FDG PET/CT) appears to be a valuable imaging technique and has been shown to have
advantages in the diagnosis of patients with fever of unknown origin. We present the case of a 52-year-
old man with a 3-year history of intermittent fever, chills, anemia, and weight loss (13 kg). He was
submitted to an extensive investigation to clarify his symptoms and all results were negative. LE was
ﬁnally diagnosed by FDG PET/CT. This examination could become a useful noninvasive method for the
detection of LE at an earlier stage, thus avoiding repeated tests and reducing the length of hospital stay.
 2013 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious
Diseases. 
Contents lists available at ScienceDirect
International Journal of Infectious Diseases
jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id
Open access under CC BY-NC-ND license.1. Introduction
The placement of pacemakers (PM) and implantable cardio-
verter deﬁbrillators (ICD) are routine procedures in current clinical
practice and they are widely available.
Lead endocarditis (LE) is one of the most feared complications
and remains a challenging diagnosis in cardiology due to the
possibility of an obscure clinical course and symptoms, leading to a
delayed diagnosis, or even no diagnosis.1
18F-ﬂuorodeoxyglucose positron emission tomography–com-
puted tomography (FDG PET/CT) appears to be a valuable imaging
technique and has been shown to have advantages in the diagnosis
of patients with fever of unknown origin.2,3 The potential value of
FDG PET/CT in the diagnosis of LE has also been demonstrated in
more difﬁcult cases with normal echocardiographic imaging
ﬁndings or persistently negative blood cultures, or both.4 The
case of a patient with chronic PM LE causing septic pulmonary
emboli, anemia, and renal insufﬁciency, with negative blood* Corresponding author. Tel.: +55 11 26615516; fax: +55 11 30817148.
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here. The presence of all these complications, negative results from
traditional examinations, and the history of a long duration of
symptoms make this case of interest.
2. Case report
A 52-year-old man was referred to our hospital with a 3-year
history of intermittent fever, chills, anemia, and weight loss
(13 kg). He had undergone PM implantation 21 years previously for
atrioventricular block, and the last generator change had been
done 6 years ago.
He had previously been admitted to another hospital to
investigate fever of unknown origin. He was submitted to an
extensive investigation to clarify his symptoms and all results were
negative. His hemoglobin level was 9.7 g/dl and creatinine level
was 3.78 mg/dl. Two blood culture sets were negative. Hepatitis B
and C virus serology and HIV serology were negative. Complement
levels and auto-antibodies (anti-deoxyribonucleic acid, anti-
extractable nuclear antigens, anti-neutrophil cytoplasmic anti-
body, antinuclear factor) were within the normal range. No
vegetations were seen on transthoracic echocardiogram (TTE) and
TEE. Ultrasonography of the generator pocket did not show signs of
infection and an abdominal ultrasound showed splenomegaly and
cholelithiasis. In order to investigate renal dysfunction, a renalociety for Infectious Diseases. Open access under CC BY-NC-ND license.
Figure 2. Chest radiography after pacemaker reimplantation with a subxiphoid
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was diagnosed. Despite this extensive investigation he was
discharged with no ﬁnal diagnosis and did not receive any
antibiotic therapy.
On admission to our hospital, physical examination revealed a
blood pressure of 100/60 mmHg and a pulse of 104/min. The
patient had a fever of 38.1 8C and no cardiac murmur. He also had
painless splenomegaly. No skin lesions were present and there
were no signs of inﬂammation or extrusion of the generator pocket.
Blood test results were as follows: white blood cell count
11.47  109/l, hemoglobin 8.6 g/dl, and C-reactive protein (CRP)
10.3 g/l. All six blood cultures collected, in the absence of previous
antibiotic use, remained sterile. Bartonella henselae, Bartonella
quintana, and Coxiella burnetii indirect immunoﬂuorescence assays
were negative. A new TEE showed no vegetations.
An FDG PET/CT scan was performed at rest, 1 h after FDG
injection, and after an 8-h fasting period. FDG PET/CT showed
hypermetabolic activity in the right subclavian region, medially,
probably in the lead’s topography, and also in the lungs, presenting
as nodules in the tomography and suggesting pulmonary
embolization (Figure 1).
Ampicillin plus oxacillin was introduced promptly and the PM
system was removed after 10 days. At surgery, the PM pocket was
opened; there were no signs of local infection and transvenous lead
extraction of both leads was done. A temporary PM was inserted
accessing by the jugular vein on the opposite side to the previous
PM. Histological examination of the lead vegetations showed
mononuclear inﬂammatory cells, and cultures yielded no growth.
The patient underwent insertion of a different PM at 14 days after
the ﬁrst surgery; the PM generator was implanted in the
subxiphoid position with an epicardial ventricular lead
(Figure 2). A follow-up FDG PET/CT scan done after completion
of antibiotic therapy (28 days) showed residual activity in the right
subclavian region and no pulmonary activity. It also identiﬁed
inﬂammatory activity in the pericardial region, pocket generatorgenerator and an epicardial ventricular lead.
Figure 1. Coronal 18F-FDG PET scan showing hypermetabolic activity in the right
subclavian region and multiple foci in both lungs suggesting septic emboli.region, and in multiple lymph nodes (Figure 3). CRP improved
directly after treatment. The patient was discharged and remains
asymptomatic after 1 year of follow-up.
3. Discussion
The rates of septicemia or endocarditis related to PM systems
range from 0.5% to 2% in published studies.5 However, the
diagnosis is not always straightforward. Some patients may
present less speciﬁc clinical manifestations, and presenting
symptoms may sometimes occur late after the intervention in
PM systems.6 A PM recipient may be hospitalized recurrently for an
infectious disorder of unknown origin despite detailed investiga-
tions.7 Our patient had an atypical clinical course of chronic PM LE
manifested 6 years after generator replacement.
Chua et al.8 found that 42% of all patients with a device infection
had a delayed presentation, and non-speciﬁc laboratory abnor-
malities such as leukocytosis, anemia, and a high sedimentation
rate were present in less than half of the cases.9
We were not able to isolate any microorganisms from either the
blood or the PM lead, and this can be explained by the following
reasons. Cultures remain negative in 2–7% of patients with
infective endocarditis, even when the utmost care is taken to
obtain the proper number and volume of blood cultures and when
patients with prior antibiotic treatment are excluded.10 Further-
more, the percentage of positive blood cultures in cardiac device-
related endocarditis is signiﬁcantly lower than in endocarditis
Figure 3. Follow-up coronal 18F-FDG PET scan showing residual activity in the right
subclavian region and no pulmonary activity. Inﬂammatory activity in the
pericardial region, pocket generator region, and at multiple lymph nodes was
also identiﬁed.
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have signiﬁcantly more negative cultures, as shown by Lekker-
kerker et al.12 and these patients have a lower number of colony-
forming units per milliliter of blood.13
The negative results of histopathological examinations and
culture from the lead vegetation could be due to antibiotic
exposure, as occurs in surgically removed heart valves from
patients with endocarditis. Morris et al.14 showed that after
antibiotic use, 28% of valve cultures and 18% of histopathological
examinations were negative, and these rates increased with each
day of antibiotic therapy prior to surgery. Another possible
explanation for the negative cultures is the occurrence of fastidious
microorganisms that do not grow or are difﬁcult to identify by the
usual culture methods.
Patients with device infections are managed as for endocarditis;
nevertheless the application of the Duke criteria to the diagnosis
has been shown to be of lower value in patients with endocarditis
on PM leads, therefore new diagnostic tools are needed.5
FDG PET/CT scanning has shown promise as a method for
locating sites of infection and could have an impact on clinical
management, but the interpretation of negative cases should be
done with caution if patients have received antibiotics.15 FDGuptake occurs in all activated leukocytes, thus enabling the
identiﬁcation of acute and chronic inﬂammatory processes.7
TEE provides information restricted to the intracardiac portion
of the leads and requires the presence of a visible vegetation. In
contrast, FDG PET/CT scanning provides information on the
intracardiac and extracardiac portions of the leads and may be
highly beneﬁcial when vegetations are not detected by TEE, since
the failure to visualize a mass adhering to a lead by TEE does not
exclude a lead infection.16
In this case, the septic pulmonary embolism was also diagnosed
by FDG PET/CT, as no pulmonary inﬁltrate had been seen on chest
radiography and there were no pulmonary symptoms.
The prevailing opinion is to remove the complete device system
if infection is conﬁrmed.16,17 All the material must be extracted as
soon as possible and the absence of removal of all infected
hardware is associated with mortality.5 The American Heart
Association guidelines do not advise system extraction in cases
with this type of presentation (negative blood cultures, no
evidence of local pocket infection, and no echocardiographic
evidence of lead infection or endocarditis), although a high level of
clinical suspicion is advised.12
An assessment of the need for new device placement is
imperative in each patient with an infected PM or ICD.
Discontinuation of PM use after removal of an infected system
has been reported in 13–52% of cases.8,10,18 It did not occur in our
case due to PM dependency.
This case demonstrates that FDG PET/CT could become a useful
noninvasive method for the detection of LE and can conﬁrm the
diagnosis at an earlier stage; as deﬁnitive therapy can then be
instigated promptly, repeated tests can be avoided and the length
of hospital stay reduced. Further studies are needed to evaluate the
relative sensitivity and speciﬁcity of FDG PET/CT compared to TTE
and TEE.
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